发明名称 EML4-ALK FUSION GENE
摘要 <p><P>PROBLEM TO BE SOLVED: To clarify a new causal gene of pulmonary cancer, thereby providing the gene, a method for detecting the gene, a kit for the detection method, a method for screening a cancer therapeutic agent and a medicinal composition. <P>SOLUTION: The present inventors have found that a fusion gene existing in some cancer patients is an oncogene, constructed a method for the detection of the gene and a protein encoded by the gene and a method for screening a protein suppressing agent (therapeutic agent for cancer positive for the fusion gene) by using the protein, and clarified that the protein suppressing agent develops an antitumor effect. According to the above findings, a new fusing gene useful as a screening tool, a fusion protein, a screening method and a medicinal composition for the treatment of cancer and positive for the fusion gene are provided. A method useful for the detection of cancer positive for the fusion gene is also provided. <P>COPYRIGHT: (C)2009,JPO&INPIT</p>
申请公布号 JP2008295444(A) 申请公布日期 2008.12.11
申请号 JP20070265917 申请日期 2007.10.11
申请人 ASTELLAS PHARMA INC;CUREGENE:KK 发明人 MANO HIROYUKI;KUROMITSU SADAO;SHINTO NOBUAKI;SOGA TAKATOSHI;FURUYA TAKASHI
分类号 C12N15/09;A61K31/506;A61K31/713;A61K45/00;A61K48/00;A61P35/00;C07D239/48;C07D401/12;C07K14/47;C07K19/00;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N9/12;C12Q1/68;G01N33/15;G01N33/50;G01N33/574 主分类号 C12N15/09
代理机构 代理人
主权项
地址